GPT Healthcare will host a virtual group meeting with analysts and investors on September 28, 2026. The session is scheduled for 11:00 am as part of the Bharat Connect-Arihant Capital conference.

The company announced the event in a filing dated September 21, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The interaction aims to provide updates based on publicly available information.

Meeting Details

The virtual conference will focus on the company's performance for the first quarter of the fiscal year ending March 2027. Representatives from GPT Healthcare will participate in the discussion.

The company emphasized that no unpublished price-sensitive information will be shared during the meeting. The discussion will rely solely on data already in the public domain.

Investor Presentation

GPT Healthcare stated that the Q1FY27 Investor Presentation is already available on its website and the stock exchanges' platforms. This presentation will serve as the basis for the dialogue with stakeholders.

Ankur Sharma, Company Secretary and Compliance Officer, issued the intimation. The company noted that changes to the schedule may occur due to exigencies.

Shareholders of company name have approved a total dividend payout of ₹2.50 per equity share of ₹10 each for the financial year ended March 31, 2026. The declaration was finalized during the company’s 37th Annual General Meeting (AGM) held on August 6, 2026, where members also transacted business related to director re-appointments and auditor remuneration. This dividend structure confirms a 25% payout ratio relative to the face value, signaling management’s confidence in cash flows despite the absence of disclosed profit figures in the proceedings summary.

The meeting, conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM), commenced at 3:00 P.M. IST and concluded at 4:26 P.M. IST. It was held in compliance with General Circular No. 03/2025 dated September 22, 2025, issued by the Ministry of Corporate Affairs (MCA), alongside the Companies Act, 2013, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sixty-six members, holding 65.60% of the company’s shares, attended the meeting, ensuring the requisite quorum was present throughout.

Key Resolutions Passed

The following ordinary and special resolutions were approved by the shareholders:

Dr. Om Tantia, Chairman and Managing Director, delivered the address, highlighting the company’s financial performance and future prospects. The statutory auditors confirmed that their report contained no qualifications, modified opinions, or adverse remarks.

Governance and Voting Details

Remote e-voting was available from August 3, 2026, to August 5, 2026, with the record date set as July 30, 2026. Mr. Ashok Kumar Daga, Practicing Company Secretary, was appointed as the Scrutinizer to oversee the voting process. The combined results of remote and during-meeting e-voting were scheduled to be communicated to the BSE and NSE within two working days of the meeting’s conclusion.

What the Numbers Show

While the specific revenue or net profit figures were not detailed in the AGM proceedings summary, the approval of a ₹1.50 final dividend on top of the ₹1 interim dividend indicates a sustained commitment to shareholder returns. The re-appointment of independent directors beyond the age of 75 (Mr. Verma) and the ratification of related-party transactions (fees for Dr. Niharika Tania and Dr. Ghanshyam Goyal) suggest a focus on continuity in governance and specialized medical consultancy support, which is critical for the healthcare sector’s operational integrity.